Skip to main content
. 2001 Dec;45(12):3482–3486. doi: 10.1128/AAC.45.12.3482-3486.2001

TABLE 3.

CFU counts in mouse lungs after 2 weeks and 6 months of treatment and after 3 months of follow-up without treatmenta

Treatment groupb Log10 CFU at 2 wk % of positive culture atc:
6 mo 9 mo
B: 6 mo of P alone 1/7 7/10*
C: 2 mo of HRZ 5/7 + 4 mo of HR 5/7 5.60 ± 0.34 0/20 1/16
D: 2 wk of SHRZ 5/7 + 5.5 mo of SHP 1/7 4.94 ± 0.32** 2/16d 11/18
E: 2 wk of SHRZ 5/7 + 5.5 mo of HP 1/7 0/16 10/18
F: 2 wk of MHRZ 5/7 + 5.5 mo of MHP 1/7 5.30 ± 0.45 0/19 2/13
G: 2 wk of MHRZ 5/7 + 5.5 mo of HP 1/7 0/18 7/14
H: 6 mo of SHPM 1/7 5.56 ± 0.25 1/19d 7/12
a

Mice were infected intravenously with 1.6 × 107 CFU of M. tuberculosis H37Rv. The next day after infection, the mean CFU count (log10) in the lungs of 10 mice was 5.01 ± 0.17, and at 2 weeks after infection, or the day treatment began, the mean value for 29 mice was 6.46 ± 0.33. A culture was considered positive if any number of colonies was detected. *, five of 7 mice harbored rifampin-resistant mutants; **, significantly different (P < 0.01) from groups C, F, and H. 

b

H, isoniazid; R, rifampin; Z, pyrazinamide; P, rifapentine; S, streptomycin; M, moxifloxacin; 1/7, once weekly; 5/7, five times weekly. 

c

Positive cultures yielded highly variable numbers of colonies ranging from one colony to a few hundred colonies. 

d

The positive cultures of lungs yielded a single colony of M. tuberculosis, and the organisms from each colony were drug susceptible